BAPRAS announcement on breast implant safety
In collaboration with the MHRA, ABS and BAAPS, BAPRAS has recently announced a joint Association perspective on Breast Implant safety.
November 2019
In response to ongoing concerns about Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), current advice from MHRA and all regulators world-wide is that those patients who have breast implants do not need to have them removed as the risks associated with surgery to remove implants and capsules outweigh the risks of potential disease. Should any of my patients who have undergone cosmetic breast augmentationin the past have concerns and/or develop breast symptoms such as swelling, lumps or pain, please feel free to contact my secretary and arrange free follow up review.
BAPRAS statement can be accessed here http://www.bapras.org.uk/
RECENTLY PUBLISHED
Practice reopening
As lockdown restrictions ease off, we are able to welcome new and follow up patients again.
Changes during Coronavirus Outbreak
Covid-19 pandemic has led to almost complete disruption of healthcare provision in the private sector over the last few weeks.
BAPRAS Winter Meeting 2019
Very pleased to have participated at the BAPRAS Winter Meeting with my own study at the upper limb section of the Congress.
BAPRAS announcement on breast implant safety
In collaboration with the MHRA, ABS and BAAPS, BAPRAS has recently announced a joint Association perspective on Breast Implant safety.
Contact
All enquiries are handled
by the Practice Manager:
Arabella Burwood
Tel: +44 (0) 845 026 7776
Email: contact@sonjacerovac.com
Correspondence address:
Miss Sonja Cerovac
Ashtead Hospital
The Warren
Ashtead, Surrey KT21 2SB